609 related articles for article (PubMed ID: 19654034)
1. Narcolepsy and depression and the neurobiology of gammahydroxybutyrate.
Mamelak M
Prog Neurobiol; 2009 Oct; 89(2):193-219. PubMed ID: 19654034
[TBL] [Abstract][Full Text] [Related]
2. [Narcolepsy: a new perspective on diagnosis and treatment].
Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
[TBL] [Abstract][Full Text] [Related]
3. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
Marti I; Valko PO; Khatami R; Bassetti CL; Baumann CR
Sleep Med; 2009 Dec; 10(10):1146-50. PubMed ID: 19464232
[TBL] [Abstract][Full Text] [Related]
4. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
Knudsen S; Gammeltoft S; Jennum PJ
Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
[TBL] [Abstract][Full Text] [Related]
5. Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy.
Baier PC; Hallschmid M; Seeck-Hirschner M; Weinhold SL; Burkert S; Diessner N; Göder R; Aldenhoff JB; Hinze-Selch D
Sleep Med; 2011 Dec; 12(10):941-6. PubMed ID: 22036605
[TBL] [Abstract][Full Text] [Related]
6. Effect of sodium oxybate on growth hormone secretion in narcolepsy patients and healthy controls.
Donjacour CE; Aziz NA; Roelfsema F; Frölich M; Overeem S; Lammers GJ; Pijl H
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1069-75. PubMed ID: 21447786
[TBL] [Abstract][Full Text] [Related]
7. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
Dauvilliers Y; Jennum P; Plazzi G
Sleep Med; 2013 Aug; 14(8):775-81. PubMed ID: 23219054
[TBL] [Abstract][Full Text] [Related]
8. Narcolepsy and the hypocretins.
Wurtman RJ
Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
[TBL] [Abstract][Full Text] [Related]
9. [Advances in the psychopharmacological management of the narcoleptic patient].
Salín-Pascual RJ; de la Fuente JR
Acta Psiquiatr Psicol Am Lat; 1985 Mar; 31(1):62-8. PubMed ID: 4050495
[TBL] [Abstract][Full Text] [Related]
10. [Hypocretin (orexin) deficiency in narcolepsy-cataplexy].
Nevsímalová S; Vanková J; Sonka K; Faraco J; Rogers W; Overeem S; Mignot E
Sb Lek; 2000; 101(4):381-6. PubMed ID: 11702580
[TBL] [Abstract][Full Text] [Related]
11. Narcolepsy and effectiveness of gamma-hydroxybutyrate (GHB): a systematic review and meta-analysis of randomized controlled trials.
Boscolo-Berto R; Viel G; Montagnese S; Raduazzo DI; Ferrara SD; Dauvilliers Y
Sleep Med Rev; 2012 Oct; 16(5):431-43. PubMed ID: 22055895
[TBL] [Abstract][Full Text] [Related]
12. Narcolepsy--master of disguise: evidence-based recommendations for management.
Mohsenin V
Postgrad Med; 2009 May; 121(3):99-104. PubMed ID: 19491546
[TBL] [Abstract][Full Text] [Related]
13. Pediatric narcolepsy.
Peterson PC; Husain AM
Brain Dev; 2008 Nov; 30(10):609-23. PubMed ID: 18375081
[TBL] [Abstract][Full Text] [Related]
14. Clinical, behavioural and polysomnographic correlates of cataplexy in patients with narcolepsy/cataplexy.
Mattarozzi K; Bellucci C; Campi C; Cipolli C; Ferri R; Franceschini C; Mazzetti M; Russo PM; Vandi S; Vignatelli L; Plazzi G
Sleep Med; 2008 May; 9(4):425-33. PubMed ID: 17681883
[TBL] [Abstract][Full Text] [Related]
15. The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy.
Weinhold SL; Seeck-Hirschner M; Nowak A; Hallschmid M; Göder R; Baier PC
Behav Brain Res; 2014 Apr; 262():8-13. PubMed ID: 24406723
[TBL] [Abstract][Full Text] [Related]
16. Sleep, Narcolepsy, and Sodium Oxybate.
Mamelak M
Curr Neuropharmacol; 2022; 20(2):272-291. PubMed ID: 33827411
[TBL] [Abstract][Full Text] [Related]
17. [Narcolepsy with cataplexy].
Dauvilliers Y; Arnulf I
Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
[TBL] [Abstract][Full Text] [Related]
18. [Integrated treatment of the symptoms of narcolepsy-cataplexy syndrome with sodium oxybate].
Poza-Aldea JJ
Rev Neurol; 2009 Jan 1-15; 48(1):27-31. PubMed ID: 19145563
[TBL] [Abstract][Full Text] [Related]
19. Narcolepsy: pathophysiology and pharmacology.
Nishino S
J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
[TBL] [Abstract][Full Text] [Related]
20. Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion.
Rye DB; Dihenia B; Bliwise DL
Depress Anxiety; 1998; 7(2):92-5. PubMed ID: 9614600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
